Maze Therapeutics, Inc. MAZE
32.43 USD +1.23 (+3.94%)
Regular-session close
32.46 +0.03 +0.09%
After hours · Nov 19, 7:43 PM ET
30.69 Day range 32.74
21.95 52-week range 53.65
- YTD
- -21.72%
- 1 year
- -8.75%
MAZE revenue history
Revenue is income from the company’s ordinary business activities.
0 USD
FY 2025 · Period ended
Coverage: incomplete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 0 | -167,500,000 | -100.00% |
| FY 2024 | 2024-12-31 | 167,500,000 | 167,500,000 | Not meaningful |
| FY 2023 | 2023-12-31 | 0 | 0 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:29.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
